amiodarone has been researched along with adenosine in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.57) | 18.7374 |
1990's | 5 (17.86) | 18.2507 |
2000's | 10 (35.71) | 29.6817 |
2010's | 12 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
DiMarco, JP; Haines, DE | 1 |
Hwang, TF; Murthy, VS | 1 |
Gutiérrez-Larraya, F; Jabón, A | 1 |
Hutchins, JB; Kennedy, T; Sausville, EA; Woosley, RL; Yasuda, SU | 1 |
Basta, M; Klein, GJ; Krahn, A; Lee, J; Yee, R | 1 |
Sharland, GK; Simpson, JM | 1 |
Trohman, RG | 1 |
Chrysostomakis, SI; Igoumenidis, NE; Kalebubas, MD; Kanoupakis, EM; Kochiadakis, GE; Simantirakis, EN; Skalidis, EI; Vardas, PE | 1 |
García Alberola, A; Gómez Agüera, A; Llamas Lázaro, C; Martínez Sánchez, J; Sánchez Muñoz, JJ; Valdés Chávarri, M | 1 |
Knowles, S | 1 |
Hampson Evans, DC; Murdoch, LJ; Ng, GY | 1 |
Grant, P | 1 |
Banchs, JE; Gonzalez, MD; Naccarelli, GV; Penny-Peterson, E; Samii, S; Wolbrette, DL | 1 |
Trappe, HJ | 2 |
Aslan, Y; Celiker, A; Dilber, B; Dilber, E; Gedik, Y; Mutlu, M | 1 |
Wehling, M | 2 |
Goodman, IS; Lu, CJ | 1 |
Alfano, F; Lanni, F; Lanzillo, T; Manganelli, F; Rosato, G; Rotondi, F; Stanco, G | 1 |
Bravo, JC; Fontanals, J; Magaldi, M; Masgoret, P; Montero-Tinnirello, J | 1 |
Ge, HY; Guo, BJ; Jiang, H; Li, AJ; Li, MT; Li, XM; Liu, HJ; Liu, XQ; Shi, L; Zhang, Y; Zhang, YY; Zheng, XC | 1 |
6 review(s) available for amiodarone and adenosine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Tachycardias: considerations in childhood in the 90s].
Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiography; Ergometry; Flecainide; Heart; Heart Ventricles; Humans; Infant; Infant, Newborn; Lidocaine; Middle Aged; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Tachycardia, Ventricular | 1993 |
Current role of pharmacologic therapy for patients with paroxysmal supraventricular tachycardia.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Calcium Channel Blockers; Digoxin; Electrocardiography; Humans; Potassium Channel Blockers; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular | 1997 |
Supraventricular tachycardia: implications for the intensivist.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Sulfonamides; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular; Verapamil; Wolff-Parkinson-White Syndrome | 2000 |
New antiarrhythmic treatment of atrial fibrillation.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Carvedilol; Cyclopropanes; Dronedarone; Fatty Acids, Omega-3; Furans; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Oligopeptides; Organic Chemicals; Peptidyl-Dipeptidase A; Potassium Channel Blockers; Propanolamines; Purinergic P1 Receptor Agonists | 2007 |
[Arrhythmias during pregnancy].
Topics: Adenosine; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Humans; Lidocaine; Pregnancy; Pregnancy Complications, Cardiovascular; Procainamide | 2008 |
22 other study(ies) available for amiodarone and adenosine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up.
Topics: Adenosine; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cause of Death; Electric Stimulation; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Stroke Volume; Survival Rate; Tachycardia, Supraventricular | 1990 |
Antiarrhythmic drugs and the modulation of autonomic control of heart rate in rabbits.
Topics: Adenosine; Amiodarone; Animals; Anti-Arrhythmia Agents; Bradycardia; Female; Heart Conduction System; Heart Rate; Male; Nadolol; Propanolamines; Rabbits; Receptors, Adrenergic, beta; Receptors, Muscarinic; Sinoatrial Node; Sympathetic Nervous System; Vagus Nerve; Verapamil | 1986 |
Amiodarone-induced lymphocyte toxicity and mitochondrial function.
Topics: Adenosine; Adult; Amiodarone; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Humans; L-Lactate Dehydrogenase; Lymphocytes; Mitochondria | 1996 |
Fetal tachycardias: management and outcome of 127 consecutive cases.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Chi-Square Distribution; Digoxin; Female; Fetal Distress; Fetus; Flecainide; Humans; Hydrops Fetalis; Maternal-Fetal Exchange; Pregnancy; Retrospective Studies; Statistics, Nonparametric; Verapamil | 1998 |
Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans.
Topics: Acute Disease; Adenosine; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Blood Flow Velocity; Blood Pressure; Coronary Circulation; Female; Heart Atria; Heart Block; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Statistics as Topic; Vascular Resistance | 2002 |
[Transient atrial fibrillation induced by adenosine in a patient with atrial tachycardia].
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Middle Aged; Tachycardia, Supraventricular; Ventricular Premature Complexes | 2002 |
Life support treatment.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Humans; Life Support Care; Myocardial Infarction; Practice Guidelines as Topic; Tachycardia, Ventricular | 2002 |
Cardiovascular collapse after amiodarone administration in neonatal supraventicular tachycardia.
Topics: Adenosine; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Emergency Medicine; Extracorporeal Membrane Oxygenation; Heart Arrest; Humans; Infant, Newborn; Infusions, Intravenous; Male; Shock; Tachycardia, Supraventricular; Treatment Outcome | 2003 |
Sustained supraventricular tachycardia in Ebstein's anomaly.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Ebstein Anomaly; Electric Countershock; Female; Humans; Middle Aged; Tachycardia, Supraventricular; Treatment Outcome | 2005 |
Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Drug Evaluation; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Defects, Congenital; Heart Failure; Heart Neoplasms; Heart Rate; Humans; Hypotension; Infant; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Male; Retrospective Studies; Rhabdomyoma; Shock, Cardiogenic; Tachycardia, Supraventricular; Thyrotropin; Treatment Outcome | 2010 |
[Life-threatening brady- and tachyarrhythmias].
Topics: Adenosine; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atropine; Bradycardia; Defibrillators, Implantable; Electric Countershock; Electrocardiography; Emergencies; Epinephrine; Heart Rate; Humans; Pacemaker, Artificial; Signal Processing, Computer-Assisted; Tachycardia | 2010 |
[Who protects physicians and patients from guidelines?].
Topics: Adenosine; Aged; Amiodarone; Anti-Arrhythmia Agents; Consensus Development Conferences as Topic; Dronedarone; Drug Approval; Early Termination of Clinical Trials; Evidence-Based Medicine; Germany; Guideline Adherence; Heart Diseases; Humans; Malpractice; National Health Programs; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Ticagrelor | 2011 |
Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia.
Topics: Adenosine; Amiodarone; Catheterization, Central Venous; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Humans; Infant; Infusions, Intraosseous; Infusions, Intravenous; Male; Procainamide; Propranolol; Recurrence; Sotalol; Tachycardia, Supraventricular; Treatment Failure; Vagus Nerve Stimulation | 2012 |
Atypical response of class IC atrial flutter to adenosine.
Topics: Adenosine; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Electrocardiography; Female; Humans; Tachycardia, Supraventricular | 2011 |
Who protects physicians and patients from guidelines?
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Drug Approval; Guideline Adherence; Humans; Patient Safety; Practice Guidelines as Topic; Practice Patterns, Physicians'; Purinergic P2Y Receptor Antagonists; Safety-Based Drug Withdrawals; Ticagrelor | 2012 |
Sinusal reversion of supraventricular tachyarrhythmias after propofol administration. A case series.
Topics: Adenosine; Adult; Aged; Amiodarone; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Female; Heart Rate; Humans; Hypnotics and Sedatives; Male; Middle Aged; Propofol; Tachycardia, Supraventricular | 2017 |
[An analysis of clinical characteristics and acute treatment of supraventricular tachycardia in children from a multicenter study].
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Female; Heart Arrest; Humans; Incidence; Infant; Male; Prospective Studies; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Ventricular Function, Left | 2018 |